Skip to main content
Glama

Compare Entities

compare_entities
Read-onlyIdempotent

"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valuesYesFor company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]).

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. First observed

TDQS

A4.7/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already indicate read-only, idempotent, non-destructive. Description adds significant context: SEC EDGAR/XBRL for companies, FAERS for drugs, handles off-calendar fiscal years, sorted results, citation URIs. No contradictions.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

Slightly long but every sentence adds value. Front-loads purpose with examples. Could be tightened but remains effective.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

No output schema, so description explains return (paired data + citation URIs). Covers edge cases (off-calendar fiscal years). For 2-param tool, description is fully complete.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage 100%, but description enhances both parameters: explains 'type' enum with data source (10-K vs FAERS), and 'values' with examples (tickers/CIKs for company, drug names) and constraints (2-5). Adds meaning beyond schema.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

Description clearly states the tool does side-by-side comparison of 2-5 companies or drugs in one parallel call. It specifies types (company or drug), data sources, and sorting. It distinguishes from siblings by explicitly preferring over sequential single-pack lookups.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

Provides explicit when-to-use examples like 'X vs Y', 'which is bigger', 'rank these companies'. Recommends always using over sequential lookups. Does not state when not to use, but context is clear.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

B3.3/5.0
Disambiguation2/5

Several tools occupy nearly the same role: ask_pipeworx and ask_pipeworx_beta are described as behaviorally identical, ask_pipeworx_grounded and deep_research both route questions across the same large catalog, and the Polymarket tools overlap heavily in intent. The ActiveCampaign list/get tools are distinct, but an agent facing 37 tools would frequently struggle to choose the right research or betting tool.

Naming Consistency2/5

Some clusters are internally consistent (list_*, ask_pipeworx_*, polymarket_*), but the server overall mixes bare verbs like remember and forget, noun phrases like entity_profile and deep_research, and brand-prefixed names like pipeworx_trending and polymarket_arbitrage. There is no unified naming convention across the tool set.

Tool Count2/5

37 tools is excessive for an ActiveCampaign integration, and only 6 of them actually relate to ActiveCampaign. The rest are a broad Pipeworx data, research, and prediction-market utility suite, so the count is not well-scoped to the server's stated purpose.

Completeness1/5

As an ActiveCampaign server, the surface is severely incomplete: it only provides read-only list/get operations and no create, update, delete, send, tag, or workflow-management tools. The unrelated Pipeworx tools may be feature-rich, but they do not fill the gaps in the named ActiveCampaign domain.